Replies to post #213767 on Biotech Values

[mcbio]

ASND +37%/AH on VSAR news (eom).

Curious if that move is warranted. I get it's a big removal of a potential key competitor. But, couldn't the fail read through to ASND's ongoing pivotal trials as well?